company background image
VIV.H logo

Avivagen TSXV:VIV.H Stock Report

Last Price

CA$0.005

Market Cap

CA$387.5k

7D

0%

1Y

-66.7%

Updated

30 Jul, 2024

Data

Company Financials

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

VIV.H Stock Overview

Focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. More details

VIV.H fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Avivagen Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Avivagen
Historical stock prices
Current Share PriceUS$0.005
52 Week HighUS$0.02
52 Week LowUS$0.005
Beta-0.21
1 Month Changen/a
3 Month Changen/a
1 Year Change-66.67%
3 Year Change-98.57%
5 Year Change-99.19%
Change since IPO-99.76%

Recent News & Updates

Recent updates

It's Unlikely That Avivagen Inc.'s (CVE:VIV) CEO Will See A Huge Pay Rise This Year

Apr 02
It's Unlikely That Avivagen Inc.'s (CVE:VIV) CEO Will See A Huge Pay Rise This Year

Shareholder Returns

VIV.HCA PharmaceuticalsCA Market
7D0%-7.4%0.7%
1Y-66.7%-57.6%13.9%

Return vs Industry: VIV.H underperformed the Canadian Pharmaceuticals industry which returned 32.2% over the past year.

Return vs Market: VIV.H underperformed the Canadian Market which returned 10.4% over the past year.

Price Volatility

Is VIV.H's price volatile compared to industry and market?
VIV.H volatility
VIV.H Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement13.4%
Market Average Movement9.7%
10% most volatile stocks in CA Market18.7%
10% least volatile stocks in CA Market4.0%

Stable Share Price: VIV.H has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine VIV.H's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005n/aG. F. Anthonywww.avivagen.com

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand.

Avivagen Inc. Fundamentals Summary

How do Avivagen's earnings and revenue compare to its market cap?
VIV.H fundamental statistics
Market capCA$387.48k
Earnings (TTM)-CA$4.64m
Revenue (TTM)CA$715.22k
0.5x
P/S Ratio
-0.1x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VIV.H income statement (TTM)
RevenueCA$715.22k
Cost of RevenueCA$409.83k
Gross ProfitCA$305.39k
Other ExpensesCA$4.95m
Earnings-CA$4.64m

Last Reported Earnings

Jul 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.06
Gross Margin42.70%
Net Profit Margin-648.74%
Debt/Equity Ratio-78.1%

How did VIV.H perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/30 22:34
End of Day Share Price 2024/07/26 00:00
Earnings2023/07/31
Annual Earnings2022/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Avivagen Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Doug CooperBeacon Securities Limited
Joseph GomesNOBLE Capital Markets, Inc.
David BautzZacks Small-Cap Research